| WHO | World Health Organization |
| CNS | Central nervous system |
| HGG | high-grade gliomas |
| LGGs | Low-Grade Gliomas |
| MRI | Magnetic resonance imaging |
| GBM | Glioblastom |
| IDH1 | Isocitrate dehydrogenase 1 |
| IHC | Immunohistochemistry |
| UPS | Ubiquitin proteasome system |
| AS | Astrocytoma |
| ODG | Oligodendroglioma |
| HDAC1 | Histone deacetylase 1 |
| NSCs | Neural stem cells |
| GSCs | Glioma stem cells |
| SVZ | Subventricular zone |
| OPCs | Oligodendrocyte progenitor cells |
| PUFAs | Polyunsaturated fatty acids |
| NAC | N-acetylcysteine |
| PE-PUFAs | Phosphatidylethanolamine PUFA |
| BBB | Blood-brain barrier |
| FasL | Fas ligand |
| TAAs | Tumor-associated antigens |
| MDSCs | Myeloid-Derived Suppressor Cells |
| CSF-1 | Colony Stimulating Factor-1 |
| Arg1+ | Arginase 1 positive |
| AEG1 | Astrocyte elevated gene-1 |
| TCGA | The Cancer Genome Atlas |
| GTEx | Genotype-Tissue Expression |
| CGGA | Chinese Glioma Genome Atlas |
| MIF | Macrophage migration inhibitory factor |
| PD-1 | Programmed cell death protein 1 |
| Tregs | Regulatory T cells |
| Tfr | T follicular regulatory |
| CTLA-4 | Cytotoxic T-Lymphocyte Associated protein 4 |
| PFG | Permeability Factor G |
| NK | Natural Killer |
| TGF-β | Transforming Growth Factor Beta |
| NKG2D | Natural-killer group 2, member D |
| IFN-γ | Interferon Gamma |
| CAR-T | Chimeric Antigen Receptor T |
| EGFRvIII | EGFR variant III |
| IL-13Rα | Interleukin-13 Receptor Alpha 2 |
| TME | Tumor microenviroment |
| Treg | Regulatory T cell |
| TIM-3 | T-cell immunoglobulin domain and mucin domain-3 |
| DCs | Dendritic cells |
| DIPG | Diffuse Intrinsic Pontine Glioma |
| SRS | Stereotactic Radiosurgery |
| CSCs | Cancer stem cells |
| TAMs | Tumor-associated macrophages |
| EVs | Extracellular vesicles |
| CX-43 | Connexin-43 |
| JNK | C-Jun N-terminal kinase |
| Grnd | Grindelwald |
| Egr | Eiger |
| BDNF | Brain-derived neurotrophic factor |
| GPER | G protein-coupled estrogen receptor |
| GICs | Glioma-initiating cells |
| AQPs | Aquaporins |
| EGFR | Epidermal growth factor receptor |
| ABAT | Aminobutyrate aminotransferase |
| PDGFRA | Platelet-derived growth factor receptor alpha |
| RNA | Ribonucleic acid |
| TFs | Transcription factors |
| lncRNA | Long non-coding RNA |
| DNA | Deoxyribonucleic acid |
| PTMS | Posttranslational modifications |
| SENP1 | SUMO-specific protease |
| miRNA | MicroRNA |
| DII1-4 | Delta-like family |
| PKB | Protein kinase B |
| PI3K | PI3 kinase |
| ACSS2 | Acetyl-CoA synthetase 2 |
| SREBP | Sterol regulatory element-binding protein-1 |
| EOR | Extent of resection |
| LOS | Length of hospital day |
| CSR | Complete surgical resection |
| IORT | Intraoperative radiation therapy |
| IoMRI | Intraoperative MRI |
| ECM | Extracellular matrix |
| TREM2 | Triggering receptor expressed on myeloid cells 2 |
| CAFs | Cancer-associated fibroblasts |
| FN1 | Fibronectin |
| MDSCs | Myeloid-Derived Suppressor Cells |
| VEGF | Vascular endothelial growth factor |
| vWF | Von Willebrand factor |
| B2R | Bradykinin receptor-2 |
| ICI | Immune checkpoint inhibition |
| CAR | Chimeric antigen receptor |
| oAds | Oncolytic adenovirus |
| DIPG | Diffuse Intrinsic Pontine Glioma |
| NSG | NOD scid gamma |
| EGR | Early growth response |
| ROS | Reactive oxidative stress |
| ER | Endoplasmic reticulum |
| IP3R | Inositol triphosphate receptor |
| TTFields | Tumor Treating Fields |
| CCNU | Lomustine |
| MGMT | Methyltransferase |
| DCVax-L | Dendritic cell vaccination |
| nGBM | Newly diagnosed glioblastoma |
| rGBM | Recurrent glioblastoma |
| OS | Overall survival |
| PD-1 | Programmed cell death protein |
| PD-L1 | Programmed cell death protein ligand 1 |
| ncRNAs | Non-coding RNAs |
| AI | Artificial intelligence |